Continuous Gastrocnemius plane block with ropivacaine
Han Liu
Phase 3 small_molecule active
Quick answer
Continuous Gastrocnemius plane block with ropivacaine for Foot Ankle Injuries is a Phase 3 program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Foot Ankle Injuries
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active